Category: Healthcare

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, and Novartis have announced the initiation of the Abu Dhabi Clinical Trials Hub through Novartis global Phase 3 programmes across neuroscience, cardiovascular disease, oncology, and immunology. Announced during the Abu Dhabi Future Health Summit 2026, the milestone marks…

Baxter International Inc. (NYSE:BAX), a leader in patient monitoring, physical assessment and vision screening products, announced the launch of the Welch Allyn Connex 360 Vital Signs Monitor in Qatar, among the first markets to introduce the technology. The launch event in Doha, brought together healthcare leaders, clinicians, and IT specialists from the Ministry of Interior,…

The Pharmaceutical Research and Manufacturers Association in Gulf (PHRMAG), the region’s leading innovative biopharmaceutical research companies, and the Authority of Social Contribution – Ma’an, the Abu Dhabi Government’s official channel to receive social contributions, has announced a strategic collaboration aimed at enabling access  for oncology and rare disease patients most in need to innovative solutions…

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate of Abu Dhabi, and Novartis Middle East FZE today signed a Memorandum of Understanding to explore collaboration in genomics research, scientific capacity building, and advanced therapies, reinforcing their shared commitment to advancing healthcare innovation and improving patient outcomes.…

GS1 UAE yesterday convened healthcare leaders, regulators, manufacturers, pharmacies, representatives from more than 20 hospitals, and industry experts at the GS1 UAE Healthcare Conference 2026 to explore how global standards are improving patient safety, strengthening traceability, and increasing operational efficiency across hospitals in the region. The conference served as a platform for healthcare stakeholders to…

The Emirates Drug Establishment (“EDE”) and Arcera Life Sciences (“Arcera”) today announced the signing of a Memorandum of Understanding (MoU) to strengthen pharmaceutical manufacturing capabilities in the UAE. Signed at Make it in the Emirates, taking place May 4-7, 2026 at ADNEC Centre Abu Dhabi, the agreement establishes a framework for collaboration across local manufacturing,…

 Arcera Life Sciences (“Arcera”), a global life sciences company headquartered in Abu Dhabi, and Shanghai Fosun Pharmaceutical Group Co., Ltd. (“Fosun Pharma”), an innovation-driven global pharmaceutical and healthcare group, today announced the signing of a Memorandum of Understanding (MoU) to establish a long-term strategic collaboration focused on licensing, technology development, neuroscience innovation and value creation…

Novartis commenced 2026 with two significant recognitions in Saudi Arabia, affirming its leadership in clinical research and contributions to the Kingdom’s developing healthcare sector. At the Clinical Trials Transformation Conference: Unraveling the Future in Riyadh, Novartis was awarded First Place in the Clinical Research Contribution Award, presented by King Faisal Specialist Hospital & Research Centre.…

The Pharmaceutical Research and Manufacturers Association of the Gulf (PHRMAG), the region’s leading innovative biopharmaceutical research companies, reaffirmed its role as a catalyst for regional healthcare transformation at the World Health Expo (WHX in Dubai). During the event, PHRMAG’s delegation participated in two high-level panel discussions highlighting the Gulf’s growing prominence as a hub for…

Mecomed, the Medical Technology Association in the Middle East and Africa, and MedTech Europe, the European trade association for medical technology industry, today brought together global and regional stakeholders  for an exclusive Mecomed & MedTech Europe exchange during WHX Dubai, a global platform for the international MedTech community, under the theme “The Power of MedTech:…